Defective Drugs

When the Medicine Causes More Harm Than the Condition

When a doctor prescribes a medication, you trust that it has been rigorously tested, properly manufactured, and accurately labeled. You trust that the risks you were told about are the real risks — not a redacted version designed to protect a pharmaceutical company’s profits.

That trust is sometimes betrayed. Defective and dangerous drugs injure and kill thousands of Americans every year — not because of medical error, not because of patient error, but because a pharmaceutical manufacturer failed in its legal duty to develop, manufacture, or warn about their product properly.

Florida Advocates represents clients throughout South Florida and Broward County who have been seriously harmed by defective or dangerous medications. These are complex cases that require attorneys who understand both the science and the law — and who are not intimidated by the resources that large pharmaceutical companies bring to every defense.

Three Types of Defective Drug Claims Under Florida Law

Defective drug cases fall under Florida product liability law. Unlike negligence cases, pharmaceutical product liability often applies strict liability to manufacturers — meaning you do not necessarily need to prove the company was careless. You need to prove the drug was defective and that defect caused your injury. There are three recognized categories:

1. Design Defect

A design defect exists when the drug’s chemical composition or formulation is inherently dangerous — when the medication itself, as designed, poses unreasonable risks to patients even when manufactured and used exactly as intended. Design defect cases often involve drugs that were brought to market before the full range of adverse effects was understood, or where safer alternative formulations existed but were not pursued.

2. Manufacturing Defect

A manufacturing defect occurs when a drug that was properly designed is contaminated, mislabeled, incorrectly dosed, or otherwise compromised during the production process. A manufacturing defect means the drug that reached you was not the drug the company intended to produce. Contamination events, recalled medication lots, and labeling errors all fall into this category.

3. Failure to Warn (Marketing Defect)

A failure to warn claim arises when a pharmaceutical company knew — or should have known — about significant risks associated with their drug, but failed to adequately communicate those risks to doctors and patients through labeling, prescribing information, or direct warnings. Pharmaceutical companies are legally required to update their labels when new safety information becomes available. When they delay or obscure those updates to protect sales, and patients are harmed as a result, a failure to warn claim may be viable.

In many defective drug cases, elements of more than one category are present. We evaluate all three in every case.

Who Can Be Held Liable for a Defective Drug Injury?

Multiple parties can bear legal responsibility in a pharmaceutical injury case:

• The drug manufacturer — for design defects, manufacturing failures, or inadequate warnings
• A contract manufacturer — if a third party manufactured or assembled the drug under license
• The drug distributor or wholesaler — for selling or distributing a drug they knew or should have known was unsafe
• The pharmacy — if a dispensing error, incorrect dosage, or failure to provide adequate instructions contributed to the harm
• The prescribing physician — in cases where off-label prescribing or failure to warn the patient of known risks constitutes medical malpractice

Identifying all liable parties is one of the most important — and most complex — aspects of a defective drug case. We conduct a thorough investigation from the outset to ensure every viable source of accountability and recovery is pursued.

Types of Serious Harm Caused by Defective Drugs

The injuries we see in pharmaceutical liability cases span a wide range of conditions, and they are almost uniformly serious:

• Heart attack, stroke, or cardiac arrhythmia from undisclosed cardiovascular risks
• Kidney or liver failure from toxic drug interactions or dosage errors
• Severe allergic reactions or anaphylaxis
• Blood clots — deep vein thrombosis or pulmonary embolism
• Neurological damage — including seizures, movement disorders, or cognitive decline
• Birth defects caused by medications taken during pregnancy
• Cancer diagnoses linked to long-term drug use
• Wrongful death — when a defective drug causes a fatal outcome

FDA Approval Does Not Mean the Drug Is Safe

One of the most common misconceptions in pharmaceutical injury cases is that FDA approval means a drug is proven safe. It does not. The FDA’s approval process evaluates whether the benefits of a drug outweigh the known risks at the time of approval — based on clinical trial data that pharmaceutical companies largely generate and submit themselves. Long-term effects, rare adverse events, and drug interactions that only appear in broader populations are often not fully known at the time of approval.

In many pharmaceutical liability cases, the harm caused by a drug only became understood after it had been on the market for months or years — after real patients experienced real consequences. A drug recall or an FDA Black Box Warning added after a drug reaches market is not a defense for the manufacturer. It is often evidence that they should have known sooner.

The fact that you were prescribed an FDA-approved medication does not eliminate your right to pursue a defective drug claim if that medication harmed you.

Mass Torts, Class Actions, and Multi-District Litigation (MDL)

When a defective drug harms a large number of people across the country, the litigation often takes the form of mass torts or multi-district litigation (MDL) — a federal mechanism for consolidating cases involving the same drug before a single judge for coordinated pretrial proceedings.

If you have been harmed by a drug that is already the subject of ongoing MDL or class action litigation, there are important implications for your case:

• You may be able to file an individual lawsuit as part of a coordinated MDL, preserving your right to individual compensation while benefiting from consolidated discovery
• Class action settlement proceeds are divided among all plaintiffs and may not fully reflect your individual damages
• MDL participation does not prevent you from pursuing separate relief in certain circumstances
• Statute of limitations issues in multi-state pharmaceutical cases require careful analysis

We evaluate every defective drug case individually — including the question of whether individual litigation or MDL participation is the right path for your specific injuries and circumstances.

Florida Statute of Limitations — Defective Drug Claims

Under Florida Statutes Section 95.11(3), product liability claims — including defective drug claims — must generally be filed within four years of the date the injury was discovered or should reasonably have been discovered. This is different from the two-year statute of limitations that applies to most personal injury claims in Florida.

However, the discovery rule — which starts the clock when you knew or should have known about the injury and its connection to the drug — can be complex to apply in pharmaceutical cases where symptoms develop gradually or a connection to medication is not immediately apparent. We analyze the applicable statute of limitations carefully in every case and advise clients on timing risks as early as possible.

Do not assume that time has run on your claim without speaking to an attorney. Contact us for a free evaluation.

What Damages Can You Recover in a Florida Defective Drug Case?

• Medical expenses — past and future treatment costs related to the drug injury
• Lost wages and reduced earning capacity
• Pain and suffering
• Permanent disability or disfigurement
• Emotional distress and psychological impact
• Wrongful death damages for surviving family members
• Punitive damages — available in cases where the manufacturer’s conduct was particularly egregious, such as knowingly concealing known risks to protect sales

About Attorney Susan Brown — Florida Advocates Personal Injury Lawyers

Susan Brown oversees the personal injury division at Florida Advocates. Before becoming an attorney, Susan worked as an insurance adjuster handling bodily injury and workers’ compensation claims. She was then recruited by the state’s largest personal injury firm — which is where she decided to pursue her law degree. That inside knowledge of how insurance companies evaluate, delay, and undervalue claims is what sets her apart from attorneys who have only ever worked on one side of a case.

Susan earned her J.D. with Honors from the University of Florida College of Law (1999), receiving the Book Award in Legal Drafting and a Trial Advocacy Scholarship. She is admitted to the U.S. District Courts for the Northern, Middle, and Southern Districts of Florida, and has argued and won cases before the Eleventh Circuit Court of Appeals. Susan is a member of the Million Dollar Advocates Forum — a designation reserved for attorneys who have achieved million-dollar-plus verdicts and settlements — and the Broward County Trial Lawyers Association.

Frequently Asked Questions — Florida Defective Drug Claims

Serving Defective Drug Victims Throughout South Florida

Florida Advocates Personal Injury Lawyers represents clients harmed by defective and dangerous pharmaceuticals throughout Broward County, Miami-Dade County, and Palm Beach County — including Fort Lauderdale, Dania Beach, Hollywood, Coral Springs, Pembroke Pines, Plantation, Weston, Hallandale Beach, Miramar, Boca Raton, and all surrounding communities.

If you or a family member has been seriously harmed by a medication, contact us today for a free, confidential case evaluation. You trusted that drug to help you. When it failed, someone should be held responsible. Let us help you find out who — and pursue the accountability your family deserves.